Results 1 to 10 of about 401 (91)
Metabolic Pathway and its Relationship to the Biological Activity of some Tuberculostatic and Leprostatic Agents [PDF]
A. E. WILDER SMITH
openaire +3 more sources
This study sought to verify the correlation between leprosy types and the adverse effects of treatment drugs. This quantitative, prospective, nested study was developed at the Dona Libânia Dermatology Centre in Fortaleza, Brazil. Data were collected from
Heitor de Sá Gonçalves +6 more
doaj +1 more source
Retreatment in leprosy: a case-control study Retratamento de hanseníase: estudo de caso-controle
OBJECTIVE: To assess risk factors for retreatment of leprosy patients. METHODS: A case-control study with patients from two reference care units in Recife, northeastern Brazil, in 2003.
Ricardo Arraes Alencar Ximenes +2 more
doaj +1 more source
OBJETIVO: Analisar fatores associados à ocorrência de recidiva em hanseníase. MÉTODOS: Estudo retrospectivo caso-controle com 159 pacientes maiores de 15 anos diagnosticados com hanseníase em cinco municípios do estado de Mato Grosso, cujas unidades de ...
Silvana Margarida Benevides Ferreira +2 more
doaj
OBJETIVO: Estimar a frequência das deficiências físicas em pacientes tratados de hanseníase após alta medicamentosa e analisar sua distribuição espacial. MÉTODOS: Estudo descritivo transversal com 232 pessoas tratadas de hanseníase de 1998 a 2006.
Susilene Maria Tonelli Nardi +3 more
doaj
Recurrent choriocarcinoma complicated with leprosy during chemotherapy: A case report and literature review. [PDF]
Hu S, Lin X, Yin R, Wang W, Li Q.
europepmc +1 more source
Skin infection by Mycobacterium marinum - diagnostic and therapeutic challenge. [PDF]
Seidel A +3 more
europepmc +1 more source
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis. [PDF]
Chew R, Woods ML.
europepmc +1 more source
Leprosy elimination: are we winning the fight or losing focus? [PDF]
Edward M, Owoicho AW.
europepmc +1 more source
Pure neural leprosy in a child: case report and diagnostic challenges. [PDF]
Santana HADR +12 more
europepmc +1 more source

